1. Home
  2. BST vs ENOV Comparison

BST vs ENOV Comparison

Compare BST & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Science and Technology Trust of Beneficial Interest

BST

BlackRock Science and Technology Trust of Beneficial Interest

HOLD

Current Price

$40.51

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$26.51

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BST
ENOV
Founded
2014
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Fluid Controls
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
BST
ENOV
Price
$40.51
$26.51
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$49.14
AVG Volume (30 Days)
112.7K
897.0K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
10.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,233,266,000.00
Revenue This Year
N/A
$9.27
Revenue Next Year
N/A
$4.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.57
52 Week Low
$27.87
$25.47
52 Week High
$44.50
$49.38

Technical Indicators

Market Signals
Indicator
BST
ENOV
Relative Strength Index (RSI) 52.62 42.26
Support Level $39.48 $26.16
Resistance Level $40.25 $27.81
Average True Range (ATR) 0.69 1.05
MACD 0.06 0.09
Stochastic Oscillator 67.06 38.52

Price Performance

Historical Comparison
BST
ENOV

About BST BlackRock Science and Technology Trust of Beneficial Interest

BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: